![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Leo Pharma A/s Ballerup Dk, based in Denmark, is a pharmaceutical company.
One of their significant offerings is Alfacalcidol, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-286 - Rev 02
This Chemical and TSE Type CEP, issued on February 18, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1286 associated with this CEP further emphasizes